Evidence map›Paper›PMID 40761631›Full record

ArticlePlastic and reconstructive surgery. Global open2025

Use of a Novel Application Technique of MatriDerm to Improve Handling and Ease.

Joanneke Maitz, Lucas Carelli, Elizabeth Coady, Duncan Loi, Peter Maitz

Abstract read
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joanneke MaitzFrom the Department of Burns and Reconstructive Surgery, Concord Repatriation General Hospital, Concord, NSW, Australia.
Lucas CarelliFrom the Department of Burns and Reconstructive Surgery, Concord Repatriation General Hospital, Concord, NSW, Australia.
Elizabeth CoadyFrom the Department of Burns and Reconstructive Surgery, Concord Repatriation General Hospital, Concord, NSW, Australia.
Duncan LoiFrom the Department of Burns and Reconstructive Surgery, Concord Repatriation General Hospital, Concord, NSW, Australia.
Peter MaitzFrom the Department of Burns and Reconstructive Surgery, Concord Repatriation General Hospital, Concord, NSW, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: MatriDerm is frequently used with a split-thickness skin graft (STSG) in a 1-stage procedure and has been clinically shown to improve the quality and appearance of reconstructed tissue. However, its fragile nature makes it challenging to use, especially when in contact with moisture or wound exudate. Recently, a novel composite application technique was described to improve the handling and ease of use of MatriDerm in a single-stage procedure. This case series uses the new application technique and discusses its outcomes. Methods: Four patients admitted between October 2022 and December 2022 to the burns and reconstructive surgery unit of Concord Repatriation General Hospital received MatriDerm applied with the new technique to their deep dermal and full-thickness injuries. All injuries were sustained by a burn, encompassing 1% total body surface area or less, and varied in anatomical location: shin, ankle, hand, and knee. Results: Complete wound closure was achieved in all patients using the new composite application technique. The method allowed for more efficient operating time, with less skin graft manipulation than the standard application technique recommended by the manufacturer. Conclusions: The results demonstrate the efficacy of a composite application technique combining MatriDerm with STSGs as a 1-stage solution for deep dermal and full-thickness wound treatment, especially in challenging anatomical areas such as digits or over joints. Initial findings suggest comparable graft success rates to standard STSG results. Despite its promising outcome, further investigations with more significant case numbers are required to further evaluate its safety, efficacy, and cost-effectiveness.

Identifiers

PMID40761631
PMCPMC12321448

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.